SDJVC
PFE icon

St. Denis J. Villere & Co’s Pfizer PFE Stock Holding History

St. Denis J. Villere & Co’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9M Sell
536,351
-38,617
-7% -$1.01M 1.54% 35
2026
Q1 		$16.1M Buy
574,968
+70,613
+14% +$1.88M 1.78% 35
2025
Q4 		$12.6M Buy
504,355
+345,820
+218% +$8.72M 1.26% 38
2025
Q3 		$4.04M Buy
158,535
+14,575
+10% +$360K 0.39% 39
2025
Q2 		$3.49M Sell
143,960
-6,460
-4% -$151K 0.34% 38
2025
Q1 		$3.81M Sell
150,420
-49
-0% -$1.28K 0.37% 38
2024
Q4 		$3.99M Sell
150,469
-23,144
-13% -$628K 0.36% 42
2024
Q3 		$5.02M Sell
173,613
-11,670
-6% -$340K 0.41% 41
2024
Q2 		$5.18M Sell
185,283
-1,715
-0.9% -$47.2K 0.44% 42
2024
Q1 		$5.19M Sell
186,998
-10,565
-5% -$293K 0.41% 40
2023
Q4 		$5.69M Sell
197,563
-13,054
-6% -$395K 0.47% 40
2023
Q3 		$6.99M Buy
210,617
+1,976
+0.9% +$69.9K 0.6% 41
2023
Q2 		$7.65M Buy
208,641
+1,126
+0.5% +$43.8K 0.55% 42
2023
Q1 		$8.47M Sell
207,515
-33,708
-14% -$1.46M 0.62% 41
2022
Q4 		$12.4M Sell
241,223
-6,275
-3% -$301K 0.96% 35
2022
Q3 		$10.8M Buy
247,498
+10,955
+5% +$532K 0.86% 38
2022
Q2 		$12.4M Sell
236,543
-3,241
-1% -$165K 0.93% 35
2022
Q1 		$12.4M Sell
239,784
-10,866
-4% -$564K 0.74% 34
2021
Q4 		$14.8M Sell
250,650
-1,135
-0.5% -$56.2K 0.85% 34
2021
Q3 		$10.8M Buy
251,785
+415
+0.2% +$18.4K 0.63% 35
2021
Q2 		$9.84M Buy
251,370
+6,110
+2% +$238K 0.53% 35
2021
Q1 		$8.88M Buy
245,260
+42,395
+21% +$1.51M 0.49% 35
2020
Q4 		$7.47M Buy
202,865
+40,849
+25% +$1.5M 0.45% 35
2020
Q3 		$5.64M Buy
+162,016
New +$5.68M 0.38% 39

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

St. Denis J. Villere & Co's PFE Position: Q2 2026 in Review

St. Denis J. Villere & Co reduced its Pfizer (PFE) stake by 6.7% in Q2 2026, selling an estimated $1.01M and leaving 536,351 shares worth $12.9M. The position accounts for 1.54% of the portfolio, ranked #35.

St. Denis J. Villere & Co first reported a position in PFE in Q3 2020 and has held it in 24 quarters since. The position peaked at $16.1M in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • St. Denis J. Villere & Co held 536,351 shares of Pfizer worth $12.9M as of Q2 2026.
  • St. Denis J. Villere & Co sold 38,617 Pfizer shares in Q2 2026, an estimated $1.01M.
  • Pfizer made up 1.54% of St. Denis J. Villere & Co's portfolio in Q2 2026, its #35 holding.
  • St. Denis J. Villere & Co first reported a position in Pfizer in Q3 2020 and has held it in 24 quarters since.
  • St. Denis J. Villere & Co's Pfizer position peaked at $16.1M in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on St. Denis J. Villere & Co's 13F filing for Q2 2026, filed 7 Aug 2026.